Review
Nature Reviews Cancer 5, 965-976 (December 2005) | doi:10.1038/nrc1750
Recent progress in the battle between oncolytic viruses and tumours
Kelley A. Parato1, Donna Senger2, Peter A. J. Forsyth2 & John C. Bell1 About the authors
Top of page
Abstract
In the past 5 years, the field of oncolytic virus research has matured significantly and is moving past the stage of being a laboratory novelty into a new era of preclinical and clinical trials. What have recent anticancer trials of oncolytic viruses taught us about this exciting new line of therapeutics?
- View At a Glance
Author affiliations
- Centre for Cancer Therapeutics, Ottawa Health Research Institute, 503 Smyth Road, Ottawa, Ontario, Canada K1H 8L6.
- Department of Medicine, Tom Baker Cancer Centre 1331 — 29 Street N.W., Calgary, Alberta, Canada T4N 4N2.
Correspondence to: John C. Bell1 Email: jbell@ohri.ca
Published online 18 November 2005
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Anticancer oncolytic activity of respiratory syncytial virusCancer Gene Therapy Original Article
See all 56 matches for Research